SOURCES SOUGHT
66 -- Equipment for Automated DNA Size Selection and Extraction
- Notice Date
- 3/27/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1130781
- Archive Date
- 4/18/2014
- Point of Contact
- Virginia C. House, Phone: 8705437405
- E-Mail Address
-
virginia.house@fda.hhs.gov
(virginia.house@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER) Laboratory of Method Development, Kensington, MD in purchasing an instrument for automated DNA separation and extraction of specific size(s) of DNA with high quality suitable for next generation sequencing analysis, and for DNA cloning following by its sequencing. Automatic equipment is required to allow accurate extraction of the necessary band size (100-50000bp) and to eliminate manual errors and prevent contamination during DNA extraction needed for performance of most of post extraction DNA applications. This is a sources sought to determine the availability and capability of small businesses manufacturers or small business capable of supplying a U.S. made product of a small business manufacturer or producer. The associated North American Industry Classification System (NAICS) Code is 334516 Analytical Laboratory Instrument Manufacturing, the Small Business Size Standard is 500 employees. Part II: Technical Requirements: A. Equipment for DNA Size Selection and Extraction capable of: - Fast separation time - separate up to 50 kb starting from 30 minutes. - Automated sizing and quantitative information in a digital format. - Automatic extracts of a target DNA with range of size 100-50000bp - Size selection can be performed using a molecular marker, thus maximizing throughput. - Each run can utilize 4-5 samples. - Consumables for use with proposed equipment (provide listing of available products). B. Deliverables Equipment for DNA Size Selection and Extraction meeting technical requirements listed above and consumables for use with the equipment. C. Service: Full Warranty including parts and labor Options for yearly service agreement for preventive and corrective maintenance beyond warranty period, a base year and up to four (4) 1 year options. D. Delivery Address: Food and Drug Administration Nicholson Lane Research Center 10903 New Hampshire Avenue Building # 52, Lab 1140 and Room # 1112-B Silver Spring, MD 20993-0002 Delivery will be expected within 30 days after receipt of order Part III: Supporting Information Coordination will be required for delivery at the Nicholson Lane Research Center. Part IV: Instructions to Prospective Respondents Responses to this sources sought shall unequivocally demonstrate that respondent has instruments/consumables capable of meeting technical requirements for the intended purposes discussed above. Though the target audience is small businesses capable of providing these items, all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; • Past performance information for sales of comparable instruments, to include description (technical literature and specifications), dollar value, client name, address, point of contact (POC), POC phone number and email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of products the responding firm is regularly engaged in providing. • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • Although this is not a request for quote, informational pricing is encouraged; • The Government encourages any comments and/or suggestions from any interested party regarding this requirement. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before April 4, 2014 by 1:00 PM (Central Time) at the Food and Drug Administration, FDA/OO/OFBA/OAGS/DAP ATTN: Virginia C. House, 3900 NCTR Road, Bldg 50/Room 432, HFT‐320, Jefferson, AR 72079‐9502 or email virginia.house@fda.hhs.gov. Reference #1130781 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. 1130781) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1130781/listing.html)
- Record
- SN03321846-W 20140329/140327234451-b69c3a57c5dc509f024f33fd3647e5d8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |